We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Zeesan Biotech Displays DNA Automated Extraction System

By LabMedica International staff writers
Posted on 05 Feb 2018
Zeesan Biotech (Fujian, China) displayed its DNA automated extraction system and real-time PCR kits for MDR/XDR-TB, HPV, HBB, etc. More...
at MEDLAB Middle East, the world’s largest attended laboratory and IVD exhibition and conference.
 
Zeesan is a biomedical company specializing in the development and production of molecular diagnostics related kits, instruments and reagents. The company’s product range includes the MeltPro series of molecular diagnostics products, automated DNA extraction machines and visible-light gel electrophoresis systems. At the MEDLAB Middle East 2018 held in Dubai, UAE, from February 5-8, 2018, Zeesan exhibited its Lab-Aid 824 nucleic acid extraction system, which enables automated, fast, reliable isolation and purification of high-quality nucleic acids for up to 24 samples per run. The entire extraction process is controlled by software and the system is intended for in vitro diagnostic use to provide high quality nucleic acid suitable for direct use in downstream application, such as amplification or other enzymatic reactions.
 
Visitors at Zeesan’s stand at the event also viewed the company’s wide range of real-time PCR kits for MDR/XDR-TB, HPV, HBB, etc. The company’s MeltPro High Risk HPV Genotyping Assay is a qualitative in vitro test kit used for HPV genotyping using cervical cells collected by swab, TCT or LCT. The test utilizes Polymerase Chain Reaction (PCR) for DNA amplification and nucleic acid hybridization for the detection of low-risk HPV types in one reaction. The MeltPro HBB test kit is meant for the detection of 12 gene mutations common in the Pakistani population, which are related to β –Thalassemia and is used for β-Thalassemia screening based on polymerase chain reaction and nucleic acid hybridization. 
 

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Monarch Mag Cell-free DNA (cfDNA) Extraction Kit provides isolation of low-abundance cfDNA from a range of biofluids (Photo courtesy of New England Biolabs)

New Extraction Kit Enables Consistent, Scalable cfDNA Isolation from Multiple Biofluids

Circulating cell-free DNA (cfDNA) found in plasma, serum, urine, and cerebrospinal fluid is typically present at low concentrations and is often highly fragmented, making efficient recovery challenging... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.